A. Sallmann
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
-
- Inflammatory mediators and NSAID effects 9
- Pharmacogenetics and Drug Metabolism 3
-
- Synthesis and Reactions of Organic Compounds 5
- Co-authors
- Peter Moser (1 shared paper)Irmgard Wiesenberg (1 shared paper)J. W. Faigle (3 shared papers)H. Stierlin (2 shared papers)R. Jaques (2 shared papers)R. Menassé (2 shared papers)P. R. Hedwall (1 shared paper)W. Küng (1 shared paper)
- Journals
- Scandinavian Journal of Rheumatology (2 papers)Inflammation Research (1 paper)Xenobiotica (1 paper)Journal of Medicinal Chemistry (1 paper)Seminars in Arthritis and Rheumatism (1 paper)
- Partner nations
- Switzerland
In The Last Decade
A. Sallmann
14 papers receiving 837 citations
Peers
Comparison fields: 5 of 109
- Pharmacology 222
- Pharmacology 394
- Pharmaceutical Science 113
- Analytical Chemistry 151
- Spectroscopy 129
Countries citing papers authored by A. Sallmann
This map shows the geographic impact of A. Sallmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sallmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sallmann more than expected).
Fields of papers citing papers by A. Sallmann
This network shows the impact of papers produced by A. Sallmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sallmann. The network helps show where A. Sallmann may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Sallmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1978 | 199 | |
| 2 | 1978 | 166 | |
| 3 | 1979 | 162 | |
| 4 | 1990 | 146 | |
| 5 | 1986 | 120 | |
| 6 | 1973 | 31 | |
| 7 | 1996 | 29 | |
| 8 | 1991 | 24 | |
| 9 | 1991 | 14 | |
| 10 | 1985 | 8 | |
| 11 | 1976 | 7 | |
| 12 | Strategies in the design of peptidoleukotriene antagonists. | 1993 | 5 |
| 13 | The chemistry of diclofenac sodium (Voltarol). | 1979 | 5 |
| 14 | CGP 35949: a potent leukotriene antagonist and inhibitor of phospholipase. Biological profile. | 1987 | 1 |
About A. Sallmann
A. Sallmann is a scholar working on Pharmacology, Organic Chemistry, Pharmacology, Analytical Chemistry and Molecular Biology, having authored 14 papers that have together received 917 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Synthesis and Reactions of Organic Compounds (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Historical Medical Research and Treatments (2 papers), Analytical Chemistry and Chromatography (2 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Pharmacology (222 citations), Pharmacology (394 citations), Pharmaceutical Science (113 citations), Analytical Chemistry (151 citations) and Spectroscopy (129 citations). A. Sallmann has collaborated with scholars based in Switzerland. Frequent co-authors include Peter Moser, Irmgard Wiesenberg, J. W. Faigle, H. Stierlin, R. Jaques, R. Menassé, P. R. Hedwall, W. Küng, H.‐P. KRIEMLER and W. J. Richter. Their work appears in journals such as Scandinavian Journal of Rheumatology, Inflammation Research, Xenobiotica, Journal of Medicinal Chemistry and Seminars in Arthritis and Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.